Correlation Between NGM Biopharmaceutica and Tryp Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NGM Biopharmaceutica and Tryp Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NGM Biopharmaceutica and Tryp Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NGM Biopharmaceuticals and Tryp Therapeutics, you can compare the effects of market volatilities on NGM Biopharmaceutica and Tryp Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NGM Biopharmaceutica with a short position of Tryp Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NGM Biopharmaceutica and Tryp Therapeutics.

Diversification Opportunities for NGM Biopharmaceutica and Tryp Therapeutics

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between NGM and Tryp is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding NGM Biopharmaceuticals and Tryp Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tryp Therapeutics and NGM Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NGM Biopharmaceuticals are associated (or correlated) with Tryp Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tryp Therapeutics has no effect on the direction of NGM Biopharmaceutica i.e., NGM Biopharmaceutica and Tryp Therapeutics go up and down completely randomly.

Pair Corralation between NGM Biopharmaceutica and Tryp Therapeutics

If you would invest  5.00  in Tryp Therapeutics on September 15, 2024 and sell it today you would earn a total of  0.00  from holding Tryp Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NGM Biopharmaceuticals  vs.  Tryp Therapeutics

 Performance 
       Timeline  
NGM Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NGM Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, NGM Biopharmaceutica is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Tryp Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

NGM Biopharmaceutica and Tryp Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NGM Biopharmaceutica and Tryp Therapeutics

The main advantage of trading using opposite NGM Biopharmaceutica and Tryp Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NGM Biopharmaceutica position performs unexpectedly, Tryp Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tryp Therapeutics will offset losses from the drop in Tryp Therapeutics' long position.
The idea behind NGM Biopharmaceuticals and Tryp Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals